Moderna, known for its Covid-19 vaccine, is focused on developing therapies using mRNA technology. The company’s vision involves turning cells into their own drug factories, showing progress in treating rare diseases. An early study on a therapy for propionic acidemia, a metabolic condition, demonstrated positive results in reducing life-threatening emergencies. Most participants were children. While the study primarily focused on safety and testing different doses, the potential for mRNA technology to revolutionize medicine is evident. Moderna’s dedication to developing innovative treatments beyond Covid-19 highlights their commitment to improving healthcare and addressing unmet medical needs.
Source link
Early data released on Moderna’s efforts to turn mRNA into medicine
